Table 7.

Antimicrobial studies performed with curcumin in polymeric drug delivery systems.

Type of Polymeric DDS	[CUR] Formulation	Microorganism	Type of Culture	Antimicrobial Method	Antimicrobial [CUR]	Light/Ultrasonic Parameters	Reference
PEG 400 γ-CD and PEG + β-CD	0.18%	E. faecalis E. coli	Planktonic	CFU/mL aPDT	N/R	9.7 J/cm2 29 J/cm2	[158]
CUR-NP without polymer	100 mg	S. aureus B. subtillis E. coli P. aeruginosa P. notatum A. niger	Planktonic	MIC Inhibition zone	100 mg 0.27 mmol	-	[159]
CUR-NP without polymer	100 mg	M. lutues S. aureus E. coli P. aeruginosa	Planktonic	MBC	N/R	-	[160]
Mixed polymer NP	5 mM	E. coli	Planktonic	MIC	400–500 μM	-	[161]
CTAB Tween 20 Sodium dodecylsulfate	100 mg/mL	L. monicytogenes	Planktonic	Inhibition zone	N/R	-	[162]
PLA/dextran sulfate	4 mg/mL	MRSA C. albicans S. mutans	Planktonic/mono- and –mixed biofilm	aPDT	260 μM	43.2 J/cm2	[163]
PLA/dextran sulfate	0.4%	C. albicans	Animal model	aPDT	260 μM	37.5 J/cm2	[164]
Nanocurcumin	N/R	P. aeruginosa (isolates) and standard strain	Planktonic	MIC	128 µg/mL	-	[165]
PLGA	5 mg	S. saprophyticus subsp. Bovis E. coli	Planktonic	aPDT	50 µg/mL	13.2 J/cm2	[166]
Eudragit L-100	N/C	L. monocytogenes	Planktonic	Animal model infection	N/R	-	[167]
nCUR	N/R	S. mutans	Planktonic Biofilm	Inhibition zone aPDT	N/R	300–420 J/cm2	[168]
nCUR combined with indocyanine	100 mg	E. faecalis	Biofilm	Metabolic activity	N/R	500 mW/cm2	[169]
PVAc-CUR-PET-PVDC	0.02 g	S. aureus S. tiphimurium	Planktonic	aPDT	N/R	24, 48, and 72 J/cm2	[170]
MOA.CUR-PLGA-NP	Up to 10%	S. mutans	Biofilm	aPDT	7% wt	45 J/cm2	[171]
CS- β-CD	N/C	S. aureus E. coli	Planktonic	Colony count	Up to 0.03%	-	[172]

[CUR]: CUR concentration. -: not performed. N/R: not reported. N/C: not clear.